PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
100.00%
Revenue growth above 1.5x 1177.HK's 5.55%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-100.00%
Negative gross profit growth while 1177.HK is at 1.36%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-100.00%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-101.92%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-101.92%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-89.25%
Dividend reduction while 1177.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-309.88%
Negative OCF growth while 1177.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-54.96%
Negative FCF growth while 1177.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-99.58%
Negative 10Y revenue/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-99.16%
Negative 5Y CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-99.62%
Negative 3Y CAGR while 1177.HK stands at 107.99%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-173.07%
Negative 10Y OCF/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-178.15%
Negative 5Y OCF/share CAGR while 1177.HK is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-168.71%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-105.22%
Negative 10Y net income/share CAGR while 1177.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-127.49%
Negative 5Y net income/share CAGR while 1177.HK is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-106.83%
Negative 3Y CAGR while 1177.HK is 84.71%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
536.80%
Dividend/share CAGR of 536.80% while 1177.HK is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
988.65%
Dividend/share CAGR of 988.65% while 1177.HK is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
33.80%
3Y dividend/share CAGR similar to 1177.HK's 34.49%. Walter Schloss finds parallel short-term dividend strategies for both companies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-56.95%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.